Accipiter Biosciences is a Seattle-based biotechnology company pioneering the design of de novo biologics for complex diseases. By leveraging advanced computational methods, the company creates multifunctional proteins that integrate multiple mechanisms in a single molecule, with the goal of delivering safer, more effective, and more convenient therapies for patients.
Leadership & Board
Current Number of Employees26
Current LinkedIn Followers1,692
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$13M
Total Amount Raised$13M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$13M
Latest Funding Amount$13M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Accipiter Biosciences had 26 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
26Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Accipiter Biosciences had 1,692 followers as of October 5, 2026. The number of followers increased by 156 (10.16%) week-over-week.
1,692Latest Followers Count
156(10.16%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.